LifeMine Therapeutics
LifeMine is a clinical-stage biopharmaceutical company revolutionizing drug discovery with its Top-Down Drug DiscoveryTM approach. This innovative method leverages evolutionary insights from fungi to identify and develop next-generation precision medicines. Their data-immersive platform integrates advanced human genetics, genomics, bioinformatics, and machine learning. The company's lead program, LIFE-001, is a novel calcineurin inhibitor targeting immune-mediated disorders and organ transplantation. Backed by leading life sciences investors, LifeMine is rapidly growing and focused on bringing breakthrough therapies to patients.
LifeMine Therapeutics
LifeMine is a clinical-stage biopharmaceutical company revolutionizing drug discovery with its Top-Down Drug DiscoveryTM approach. This innovative method leverages evolutionary insights from fungi to identify and develop next-generation precision medicines. Their data-immersive platform integrates advanced human genetics, genomics, bioinformatics, and machine learning. The company's lead program, LIFE-001, is a novel calcineurin inhibitor targeting immune-mediated disorders and organ transplantation. Backed by leading life sciences investors, LifeMine is rapidly growing and focused on bringing breakthrough therapies to patients.